AI Tools Offer Problematic Health Advice About Half the Time, Study Finds
As more Americans rely on AI tools and chatbots for health insights, new research shows potentially serious risks. Learn why and how to use AI safely.
7 mistakes we all make that ruin the diet
Ahead of the approaching summer, dietitian Dr. Maya Rosman explains which mistakes you are making on the way to your ideal weight.
Beshear signs measure o strengthen SNAP workforce initiatives
HB 781 will take effect 90 days after the legislature adjourns.
Senior Farmer’s Market Nutrition Program to begin in Southside
Virginia’s Farm Market Fresh for Seniors — also known as the Senior Farmer’s Market Nutrition Program — is available through the Southern Area Agency on Aging.
EPA Delays Decisions on ‘Forever Chemicals’ MedNews
WEDNESDAY, April 15, 2026 The U.S. Environmental Protection Agency (EPA) has paused decisions on uses for dozens of forever chemicals, also known as PFAS.The de
Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans MedNews
WEDNESDAY, April 15, 2026 Buying or selling wild animals, whether for food, pets or other uses, may increase the risk of diseases spreading to people, a new stu
Yes, This is the Worst Pollen Season Ever — Until Next Year MedNews
WEDNESDAY, April 15, 2026 When I was training to be a board-certified allergist 20 years ago, a running joke cropped up every spring. Local media outlets loudly
New Weight Loss Pill Gets Approval But FDA Seeks More Safety Data MedNews
WEDNESDAY, April 15, 2026 The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity
STAT+: FDA panel will meet to discuss allowing broader access to certain peptides
WASHINGTON — The Food and Drug Administration will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain peptides, the agency announced on Wednesday. The meetings
New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data MedNews
WEDNESDAY, April 15, 2026 The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity